News

October 9, 2024

Announcing Spiderwort's CelluBridge Clinical Advisory Board 

Pioneers in Neuroscience Join Forces with Spiderwort to Revolutionize Spinal Cord Injury Treatment Ottawa, Canada — October 9, 2024 — Spiderwort Inc., the biotechnology company innovating in cellulose-based tissue engineering, today announced its Clinical Advisory Board for CelluBridge, the firm’s […]

April 8, 2024

Spiderwort Co-Founders at Techcracker 2024 in Japan

Spiderwort collaborates with entrepreneurs and innovators in life sciences, March 2024. Spiderwort’s co-founders, Dr. Charles M. Cuerrier and Dr. Andrew Pelling travelled to Japan for the Techcracker 2024 and Techcracker Labs events, hosted by Horizons Ventures.  Celebrating its 10th anniversary […]

January 25, 2024

Spiderwort at IMCAS World Congress 2024

Celebrating Innovation in Medical Aesthetics Ottawa, Canada  — January 25, 2024 — Spiderwort, the biotech company transforming regenerative medicine, will attend the IMCAS World Congress next week in Paris, France from February 1-3, 2024. This year marks the 25th anniversary […]

December 21, 2023

Spiderwort’s 2023 Year in Review: Advancing Innovation in Regenerative Medicine

As 2023 comes to a close, we look back at the progress and advancement we’ve made to push the boundaries of regenerative medicine through our continued investment in cellulose-based biomaterial research and development. Both of our product lines — CelluBridge and […]

December 5, 2023

Introducing Spiderwort's CelluJuve® Clinical Advisory Board

Top Aesthetic Medical Professionals Team Up with Spiderwort to Redefine Dermal Filler Innovations Ottawa, Canada — December, 5, 2023 — Spiderwort Inc., the biotechnology company innovating in plant-based tissue engineering, today announced its Clinical Advisory Board for CelluJuve®, the firm’s […]

November 28, 2023

Spiderwort Executive Joins Canada's Premier Biotech Leadership Development Program

Dr. Stephen Hanson, Spiderwort Business Development Director, Joins Elite Cohort Ottawa, Canada — November,28, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce its Business Development Director, Dr. Stephen Hanson, has been selected […]

November 22, 2023
News Release

Spiderwort Selected to Join Elite CELS Valley Ready Program

Admission to Prestigious Program to Bolster Biotechnology Firm’s Global Reach in Life Sciences Ottawa, Canada — November, 22, 2023 — Spiderwort Inc., the biotechnology company innovating in cellulose-based tissue engineering, today announced its acceptance to the prestigious Canadian Entrepreneur in […]

October 27, 2023
News Release

Spiderwort Embarks on November European Tour

Forging Global Partnerships in Regenerative Medicine Ottawa, Canada  — October, 27, 2023 — Spiderwort Inc, the biotech company leading in regenerative medicine, will embark on a regional European tour this upcoming November with a focus on building partnerships with researchers, […]

June 6, 2023
News Release

Spiderwort Accepted to Tech Accelerator, MaRS Health Science Portfolio

This important milestone follows Spiderwort’s graduation to Invest Ottawa’s “ScaleUp” venture development program Ottawa — June 6, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce it has been accepted to the prestigious […]

February 7, 2023
News Release

Spiderwort Wins Prestigious Judge's Choice Award at Industry-Leading Octane Medical Aesthetics Tech Forum

This award follow’s Spiderwort’s inaugural presentation to the medical aesthetics industry in the U.S. market. Ottawa — February 7, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce it has been selected as […]

Please contact us for press kit or media inquiries.

Contact Us

Hear More From Us